Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Robert K. who wrote (4844)	11/23/1997 10:24:00 AM
From: chirodoc	Read Replies (1) \| Respond to of 17367

<<<<<<For you scientific types, here is a rehash ofwhat I THINK bpi can do ...wonderful summary--since I am not a biotechnologist--I hate to say anything but praise you for your wonderful outline. ......my only question is can xoma parlay this into income in the next 1-2 years. ....... I believe that the research shows it is a great molecule!

To: Robert K. who wrote (4844)	11/23/1997 11:02:00 AM
From: Robert K.	Respond to of 17367

And my choice of terms on note 4840 may not be optimal, but the net result is essentially the same. Example lbp competitively competes with bpi for binding and stimulation of cd-14 receptor. (just rechecking my post). Please remember wording is not optimal, I just thru that stuff up there on 4840.